Characterization and Management of Arrhythmic Events in Young Patients with Brugada Syndrome.
Yoav Michowitz,Anat Milman,Antoine Andorin,Georgia Sarquella-Brugada,M Cecilia Gonzalez Corcia,Jean-Baptiste Gourraud,Giulio Conte,Frederic Sacher,Jimmy J M Juang,Sung-Hwan Kim,Eran Leshem,Philippe Mabo,Pieter G Postema,Aviram Hochstadt,Yanushi D Wijeyeratne,Isabelle Denjoy,Carla Giustetto,Yuka Mizusawa,Zhengrong Huang,Camilla H Jespersen,Shingo Maeda,Yoshihide Takahashi,Tsukasa Kamakura,Takeshi Aiba,Elena Arbelo,Andrea Mazzanti,Giuseppe Allocca,Ramon Brugada,Ruben Casado-Arroyo,Jean Champagne,Silvia G Priori,Christian Veltmann,Pietro Delise,Domenico Corrado,Josep Brugada,Kengo F Kusano,Kenzo Hirao,Leonardo Calo,Masahiko Takagi,Jacob Tfelt-Hansen,Gan-Xin Yan,Fiorenzo Gaita,Antoine Leenhardt,Elijah R Behr,Arthur A M Wilde,Gi-Byoung Nam,Pedro Brugada,Vincent Probst,Bernard Belhassen
DOI: https://doi.org/10.1016/j.jacc.2019.01.048
IF: 24
2019-01-01
Journal of the American College of Cardiology
Abstract:BACKGROUND:Information on young patients with Brugada syndrome (BrS) and arrhythmic events (AEs) is limited.OBJECTIVES:The purpose of this study was to describe their characteristics and management as well as risk factors for AE recurrence.METHODS:A total of 57 patients (age ≤20 years), all with BrS and AEs, were divided into pediatric (age ≤12 years; n = 26) and adolescents (age 13 to 20 years; n = 31).RESULTS:Patients' median age at time of first AE was 14 years, with a majority of males (74%), Caucasians (70%), and probands (79%) who presented as aborted cardiac arrest (84%). A significant proportion of patients (28%) exhibited fever-related AE. Family history of sudden cardiac death (SCD), prior syncope, spontaneous type 1 Brugada electrocardiogram (ECG), inducible ventricular fibrillation at electrophysiological study, and SCN5A mutations were present in 26%, 49%, 65%, 28%, and 58% of patients, respectively. The pediatric group differed from the adolescents, with a greater proportion of females, Caucasians, fever-related AEs, and spontaneous type-1 ECG. During follow-up, 68% of pediatric and 64% of adolescents had recurrent AE, with median time of 9.9 and 27.0 months, respectively. Approximately one-third of recurrent AEs occurred on quinidine therapy, and among the pediatric group, 60% of recurrent AEs were fever-related. Risk factors for recurrent AE included sinus node dysfunction, atrial arrhythmias, intraventricular conduction delay, or large S-wave on ECG lead I in the pediatric group and the presence of SCN5A mutation among adolescents.CONCLUSIONS:Young BrS patients with AE represent a very arrhythmogenic group. Current management after first arrhythmia episode is associated with high recurrence rate. Alternative therapies, besides defibrillator implantation, should be considered.